Effect of melphalan and hyperthermia on p34(cdc2) kinase activity in human melanoma cells

L. Orlandi, N. Zaffaroni, A. Bearzatto, R. Silvestrini

Research output: Contribution to journalArticlepeer-review


We previously reported that combined treatment with melphalan and mild hyperthermia (1 h at 42°C) caused a synergistic cytotoxic effect in JR8 melanoma cells, paralleled by a stabilisation of a melphalan induced G2-phase cell block. In this study, we investigated the effect of melphalan and hyperthermia on proteins that regulate G2-M transition. Neither hyperthermia nor melphalan at a concentration 2.5 μg ml-1, which had no antiproliferative effect at 37°C, interfered with cyclin B1 expression or p34(cdc2) kinase activity. At a concentration of 8.5 μg ml-1, which reduced cell growth by 50% at 37°C, melphalan inhibited p34(cdc2) kinase activity as a consequence of an increased tyrosine phosphorylation of the protein. A similar inhibitory effect on p34(cdc2) kinase was obtained when the lowest melphalan concentration (2.5 μg ml-1) was used under hyperthermic conditions. Our results indicate that thermal enhancement of melphalan cytotoxicity could be mediated at least in part by an inhibition of p34(cdc2) kinase activity, which prevents cell progression into mitosis.

Original languageEnglish
Pages (from-to)1924-1928
Number of pages5
JournalBritish Journal of Cancer
Issue number12
Publication statusPublished - 1996


  • Cyclin B
  • G-M transition
  • Hyperthermia
  • Melanoma
  • Melphalan
  • P34(cdc2)

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Effect of melphalan and hyperthermia on p34(cdc2) kinase activity in human melanoma cells'. Together they form a unique fingerprint.

Cite this